In contrast to VCAM-1, attachment of T-ALL cells to fibronectin did not activate PYK2, which is in line with the failure of fibronectin to induce doxorubicin efflux and resistance. The gene discussed is VCAM1; the disease is acute lymphoblastic leukemia.